t(9;11)(p22;p15) [NUP98/PSIP1] is a poor prognostic marker associated with de novo acute myeloid leukaemia expressing both mature and immature surface antigens

Leukemia Research

Volumn 35, Issue 6, 2011, Pages

  Lundin, Catarina ^a   Horvat, Andrea ^a   Karlsson, Karin ^a   Olofsson, Tor ^a   Paulsson, Kajsa ^a   Johansson, Bertil ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD123 ANTIGEN; CD135 ANTIGEN; CD15 ANTIGEN; CD2 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; CD65 ANTIGEN; CYTARABINE; DAUNORUBICIN; HEMOGLOBIN; HLA DR ANTIGEN; MEMBRANE ANTIGEN; MICROSOMAL AMINOPEPTIDASE; MYELOPEROXIDASE; STEM CELL FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ANEMIA; BONE MARROW BIOPSY; CANCER GROWTH; CASE REPORT; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 9; FATALITY; FATIGUE; FEMALE; FLT3 GENE; FUSION GENE; GENE; HUMAN; IMMUNOPHENOTYPING; KARYOTYPE 46,XX; LETTER; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LEUKOCYTE COUNT; MULTIPLE CYCLE TREATMENT; MYELOBLAST; NUP98 GENE; PNEUMONIA; PRIORITY JOURNAL; PSIP1 GENE; WEIGHT REDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTIGENS, CD; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 9; FEMALE; HUMANS; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, MYELOID, ACUTE; MIDDLE AGED; NUCLEAR PORE COMPLEX PROTEINS; ONCOGENE PROTEINS, FUSION; PROGNOSIS; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 79955621847     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2010.11.022     Document Type: Letter

References (10)

1. Lam D.H., Aplan P.D. NUP98 gene fusions in hematologic malignancies. Leukemia 2001, 15:1689-1695.
2. Romana S.P., Radford-Weiss I., Ben Abdelali R., Schluth C., Petit A., Dastugue N., et al. NUP98 rearrangements in hematopoietic malignancies: a study of the Groupe Francophone de Cytogénétique Hématologique. Leukemia 2006, 20:696-706.
3. Mitelman F., Johansson B., Mertens F. Mitelman database of chromosome aberrations in cancer 2010, (WWW document) http://cgap.nci.nih.gov/Chromosomes/Mitelman (accessed on 8 October 2010).
4. Chou W-C., Chen C-Y., Hou H-A., Lin L-I., Tang J-L., Yao M., et al. Acute myeloid leukemia bearing t(7;11)(p15;p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: comparative analysis of 493 adult patients. Leukemia 2009, 23:1303-1310.
5. Ahuja H.G., Hong J., Aplan P.D., Tcheurekdjian L., Forman S.J., Slovak M.L. t(9;11)(p22;p15) in acute myeloid leukemia results in a fusion between NUP98 and the gene encoding transcriptional coactivators p52 and p75-lens epithelium-derived growth factor (LEDGF). Cancer Res 2000, 60:6227-6229.
6. Ha S.Y., Chan L.C. Biphenotypic leukemia with t(9;11)(p22;p15). Cancer Genet Cytogenet 1994, 76:116-117.
7. Hussey D.J., Moore S., Nicola M., Dobrovic A. Fusion of the NUP98 gene with the LEDGF/p52 gene defines a recurrent acute myeloid leukemia translocation. BioMed Central Genet 2001, 2:20.
8. Grand F.H., Koduru P., Cross N.C.P., Allen S.L. (2005) NUP98-LEDGF fusion and t(9;11) in transformed chronic myeloid leukemia. Leuk Res 2005, 29:1469-1472.
9. Morerio C., Acquila M., Rosanda C., Rapella A., Tassano E., Micalizzi C., et al. t(9;11)(p22;p15) with NUP98-LEDGF fusion gene in pediatric acute myeloid leukemia. Leuk Res 2005, 29:467-470.
10. Gilliland D.G. Molecular genetics human leukemias: new insights into therapy. Semin Hematol 2002, 39:6-11.